Articles with "gastric gist" as a keyword



Photo from wikipedia

The True Incidence of Gastric GIST: an Update

Sign Up to like & get
recommendations!
Published in 2018 at "Obesity Surgery"

DOI: 10.1007/s11695-018-3235-7

Abstract: Gastrointestinal stromal tumor (GIST) is a rare neoplasm of the alimentary tract with an incidence of around 1 per 100,000 [1]. The most common location is in the stomach where 60% of these tumors occur… read more here.

Keywords: incidence; true incidence; incidence gastric; gist ... See more keywords
Photo from wikipedia

Effectiveness of laparoscopic surgery in patients with large gastric GIST (diameter > 5cm).

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2019.37.4_suppl.35

Abstract: 35 Background: Recently, the application of laparoscopic or DaVinci surgery in relatively small gastrointestinal stromal tumors (GIST) has been increasingly recognized. However, the use in large stromal tumors, especially with a diameter greater than 5… read more here.

Keywords: large gastric; gastric gist; surgery; laparoscopic surgery ... See more keywords
Photo from wikipedia

Gastrointestinal stromal tumors of the stomach: A 10-year experience of a single-center

Sign Up to like & get
recommendations!
Published in 2021 at "Nigerian Journal of Clinical Practice"

DOI: 10.4103/njcp.njcp_558_20

Abstract: Background: Gastrointestinal tract stromal tumors (GIST) are the most common mesenchymal tumors in the gastrointestinal tract (GIS). GISTs may cause significant morbidity and mortality rates. Aim: In this study, it was aimed to evaluate 10… read more here.

Keywords: tumor; stromal tumors; single center; year ... See more keywords
Photo from wikipedia

Pathologic Complete Response in a Large Gastric GIST: Using Molecular Markers to Achieve Maximal Response to Neoadjuvant Imatinib.

Sign Up to like & get
recommendations!
Published in 2018 at "Journal of the National Comprehensive Cancer Network : JNCCN"

DOI: 10.6004/jnccn.2018.7063

Abstract: Gastrointestinal stromal tumors (GISTs) represent 1% of alimentary tract neoplasms. Up to 90% of GISTs are driven by activating mutations in tyrosine kinase KIT or PDGFRα genes. Imatinib mesylate is a tyrosine kinase inhibitor that… read more here.

Keywords: response; neoadjuvant imatinib; gist; pathologic complete ... See more keywords